Breadcrumb

2030 Vision

Built upon a shared vision of advancing precision health, our 2030 Vision builds toward a future where the Research Institute of the McGill University Health Centre (RI-MUHC) is globally recognised as a leader in transformative discoveries that advance human health throughout the life course.

Our 2030 Vision outlines our strategic initiatives to realise precision health research through five research priorities to help researchers develop scientific breakthroughs and improve patient care, and four enabling priorities to ensure we build an outstanding working environment for research success.

Download the 2030 Vision brochure (pdf, published November, 2024)

Download the complete 2030 Vision (pdf, published June 2024)

Our Values

Our values are shaped by the origin of the RI-MUHC, its history, its present, and its future.

VARIED PERSPECTIVES : Diversity in viewpoints, experience, and what we study strengthens our science

FREEDOM TO INNOVATE : Curiosity and broad exploration enables impactful discoveries

COLLABORATION: Working together across disciplines, domains, and communities to cultivate innovation

MENTORSHIP: Fostering learning and growth for everyone maximises our collective potential

INTEGRITY: Honesty, transparency, trust, and ethical rigour keep us fair and accountable

Guiding Principles

These principles represent our collective commitments in pursuit of our purpose, shaping our scientific focus and operations.

TRANSVERSAL COLLABORATIONS: We prioritise the creation and strengthening of bridges across domains. Collaboration between the professions, disciplines, programs, centres, locations, healthcare organisations, and our research environment is fundamental to unlocking novel and impactful discoveries.

PATIENT-ORIENTED RESEARCH: We focus on research that informs prevention, care, and outcomes for patients, their families, and communities. Each activity, decision, process, and policy should enable research outcomes that support greater understanding of, and improvements to, patient and population well-being.

Path to developing our shared plan

Our Vision

Our vision: Advancing precision health throughout the life course.

By 2030, the RI-MUHC will be globally recognised as a leading research institute in transformative discoveries and innovations that advance precision health throughout the life course using a precision health strategy.

Our Strategic Priorities

For more details about each of our research priorities and our enabling priorities, download the complete 2030 Vision (pdf, published June 2024)

Our next steps

While the 2030 Vision (2024-2030) is a fixed strategic plan that defines institutional commitments at the priority and objective levels, the Implementation Plan is a living document that outlines the measurable deliverables underpinning the realization of this Vision. As a living document, the Implementation Plan will be divided into phases of two-year increments to permit revision, refinement, and reevaluation over six years. To achieve the ambitions set forth in the 2030 Vision, we have developed Implementation Plans for both the Enabling Priorities and the Research Priorities.

Enabling Priorities Implementation Plan

Phase 1 of the Enabling Priorities Implementation Plan (2024-2026) Each administrative division worked with the Research Strategy Office to develop key division-specific deliverables that advance specific objectives across the four Enabling Priorities. This plan underwent its first complete year of quarterly monitoring in 2025 (Q1-Q4).

Research Priorities Implementation Plan

In 2025, five Research Priority Leaders were selected through a competitive application process, and each Leader established a cross-programmatic advisory committee to guide the research focus of their respective priorities.

Research Priority Leader 1: Julia Burnier, PhD

Research Priority Leader 2: Abhinav Sharma, MD, PhD

Research Priority Leader 3: David Buckeridge, MD, PhD

Research Priority Leader 4: Sushmita Pamidi, MD

Research Priority Leader 5: Annette Majnemer, OT, PhD

We are finalizing Phase 1 of the Research Priorities Implementation Plan (2026-2027), which will be developed through a two-tiered approach:

In tier 1, each Research Priority Leader will identify two to three priority-specific flagship research projects; for each project, the Research Strategy Office will develop a proactive funding strategy to ensure that these projects are submitted to strategically-aligned funding opportunities across peer-reviewed, philanthropic, and industry-based organizations. The principal investigator of each flagship project will receive targeted institutional support to bolster the readiness of their funding application. Institutional operational needs across both the Enabling and Research Priorities will be embedded within these funding applications to ensure that, by supporting each flagship project, The Institute simultaneously enhances research capacity for our entire community.

In tier 2, we will select transformative and priority-crossing research themes upon which to mobilize our research community. Specifically, in alignment with selected research themes, we will:

  • Launch an Institute-wide call for applications in 2026;
  • Deploy a funding campaign across the Foundations; and
  • Align internal funding competitions to support these themes.

The details of the selected flagship projects and priority-crossing research themes for 2026-2027 will be shared in the Phase 1 Research Implementation Plan in early 2026.

Our 2030 Vision – Annual Update 2025

Acknowledgements

Explore research at the RI-MUHC